Advanced search

Daratumumab (anti-CD38) induces loss of CD38 on red blood cells.

Harold C Sullivan, Christian Gerner-Smidt, Ajay K Nooka, Connie M Arthur, Louisa Thompson, Amanda Mener, Seema R Patel, Marianne Yee, Ross M Fasano, Cassandra D Josephson, Richard M Kaufman, John D Roback, Sagar Lonial, Sean R Stowell

Journal: Blood 2018;129(22):3033-3037

PMID: 28373263

Free Full Text on Elsevier Science View on PubMed

Abstract

Address: Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine.; Department of Hematology and Medical Oncology, and.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; and.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
DOI: 10.1182/blood-2016-11-749432

Link outs

Free resources

Full Text Sources:

Medical:

Other Literature Sources:

Research Materials:

Subscription / membership required

Full Text Sources:

MeSH Terms: ADP-ribosyl Cyclase 1, Antibodies, Monoclonal, Erythrocytes, Female, Humans, Male, Membrane Glycoproteins, Multiple Myeloma
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor Sponsor Sponsor Sponsor Sponsor Sponsor Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.